Hospital
Clarksdale Hma LLC
Clarksdale Hma LLC was paid $820K by Medicaid between Jan 2018 and Jun 2021, across 116 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.
33Billing provider infoCLARKSDALE HMA LLC
CLARKSDALE, MS 38614
CLARKSDALE, MS 38614
33aNPI1376584110assigned 06/10/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$820K
24GClaims46,854
24DCodes billed116
24AFirst – last monthJan 2018 – Jun 2021
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#51 of 77
Median peer was paid$8.23M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,176 | $18K | |
| 2019 | 11,162 | $146K | |
| 2020 | 13,446 | $421K | |
| 2021 | 7,070 | $235K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 2,966 | 1,881 | $156K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 1,537 | 1,101 | $136K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.0% | 720 | 515 | $66K |
| G0378 | Hospital observation service, per hour | 7.8% | 459 | 193 | $64K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.8% | 853 | 383 | $39K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.2% | 525 | 277 | $34K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.1% | 2,128 | 1,220 | $34K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.3% | 728 | 470 | $27K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.8% | 845 | 612 | $23K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.1% | 641 | 442 | $17K |
| 71045 | Radiologic examination, chest; single view | 2.1% | 921 | 601 | $17K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.5% | 935 | 674 | $13K |
104 more codes
| 80053 | Comprehensive metabolic panel | 1.3% | 3,409 | $11K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.2% | 150 | $10K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.1% | 217 | $9K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.1% | 441 | $9K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.1% | 265 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.0% | 829 | $9K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.0% | 263 | $8K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 556 | $8K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 342 | $8K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 184 | $6K |
| 83880 | <1% | 416 | $6K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 288 | $6K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 37 | $6K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,441 | $5K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 273 | $5K |
| 59025 | Fetal non-stress test | <1% | 100 | $5K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 246 | $5K |
| 86900 | <1% | 63 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 447 | $4K |
| 84484 | <1% | 670 | $3K | |
| 85027 | <1% | 1,500 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,045 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 443 | $3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 30 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 264 | $2K |
| 36600 | <1% | 39 | $2K | |
| 87430 | <1% | 687 | $2K | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 51 | $2K |
| 82731 | <1% | 61 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 29 | $2K |
| 82805 | <1% | 41 | $1K | |
| 80306 | <1% | 226 | $1K | |
| 83735 | <1% | 633 | $1K | |
| 86850 | <1% | 51 | $1K | |
| 84703 | <1% | 528 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 127 | $1K |
| 86901 | <1% | 63 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 52 | $1K |
| 71250 | <1% | 19 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 442 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 322 | $1K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 20 | $1K |
| 81001 | <1% | 1,287 | $1K | |
| 94060 | <1% | 13 | $1K | |
| 80061 | Lipid panel | <1% | 186 | $968.18 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 339 | $959.43 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 16 | $938.94 |
| 87040 | <1% | 220 | $934.61 | |
| 94726 | <1% | 13 | $812.95 | |
| 83690 | <1% | 458 | $784.59 | |
| 73030 | <1% | 16 | $782.27 | |
| 73560 | <1% | 39 | $747.82 | |
| 97035 | <1% | 96 | $712.86 | |
| 85730 | <1% | 384 | $670.81 | |
| 85610 | <1% | 512 | $642.20 | |
| 76642 | <1% | 16 | $543.86 | |
| 83605 | <1% | 86 | $510.59 | |
| 82607 | <1% | 49 | $490.63 | |
| 87210 | <1% | 370 | $490.11 | |
| 84702 | <1% | 98 | $481.44 | |
| 51702 | <1% | 14 | $449.34 | |
| 97033 | <1% | 37 | $428.91 | |
| 73630 | <1% | 14 | $428.82 | |
| 82962 | <1% | 245 | $422.96 | |
| 81003 | <1% | 558 | $383.88 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 802 | $364.67 |
| 86140 | <1% | 125 | $257.20 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 486 | $242.25 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 213 | $201.27 |
| 80069 | <1% | 29 | $182.71 | |
| 87186 | <1% | 73 | $156.54 | |
| 87420 | <1% | 101 | $151.80 | |
| 84439 | <1% | 47 | $150.14 | |
| 82570 | <1% | 29 | $96.24 | |
| J3490 | Unclassified drugs | <1% | 1,226 | $76.37 |
| 85651 | <1% | 17 | $68.50 | |
| 84156 | <1% | 31 | $66.21 | |
| 83615 | <1% | 15 | $60.09 | |
| 82150 | <1% | 174 | $58.36 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 47 | $21.26 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 335 | $1.34 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 380 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 32 | $0.00 |
| 96376 | 0% | 99 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 94 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 53 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 165 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 15 | $0.00 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 156 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 108 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 114 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 18 | $0.00 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 43 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 227 | $0.00 |
| 84145 | 0% | 46 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 281 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 353 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 510 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 518 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 70 | $0.00 |
| 76818 | 0% | 102 | $0.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 42 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 28 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.